FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA] - N0000194085

Name: Table of NDC products with fms-like receptor tyrosine kinase 3 (flt3) inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000194085
Pharmacologic Name	FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	65597-504	Vanflyta	Non-Proprietary Name: Quizartinib	Tablet, Film Coated	Oral	Daiichi Sankyo Inc.	ACTIVE
	65597-511	Vanflyta	Non-Proprietary Name: Quizartinib	Tablet, Film Coated	Oral	Daiichi Sankyo Inc.	ACTIVE